J Korean Cleft Palate-Craniofac Assoc.  2008 Apr;9(1):23-26.

Treatment of Salivary Duct Carcinoma: A Case Report

Affiliations
  • 1Department of Plastic Surgery, The Catholic University of Korea College of Medicine, Gyeonggi, Korea. prsdrlim@yahoo.com

Abstract

Salivary duct carcinoma is a high-grade adenocarcinoma arising from the ductal epithelium and has very low prevalence. We report a case of salivary duct carcinoma in high risk group with satisfactory result. A 65-year-old male was referred to our clinic complaining of mass on Rt. cheek. Preoperative CT and MRI shows 2.0x1.9cm sized multilobulated, cystic mass on the superficial lobe of Rt. parotid gland and multiple lymph node enlargement thorough the Rt. internal jugular chain. Total parotidectomy and modified radical neck dissection with adjuvant radiation therapy was performed. Pathologic result was salivary duct carcinoma and resection margin was free. Postoperative radiation therapy with 6400cGy(200cGyx 12 fx) was performed. During the 24-months of follow up periods, recurrence or complications associated with operation and radiation therapy was not observed. Salivary duct carcinoma is rare disease with very poor prognosis. Lymph node metastasis is commonly accompanied at the time of diagnosis. Distant metastasis is the most common cause of death. Total parotidectomy, radical neck disssection and adjuvant radiation therapy can be the appropriate modality for the control of the salivary duct carcinoma especially in high risk group.

Keyword

Salivary duct carcinoma; Parotid mass

MeSH Terms

Adenocarcinoma
Aged
Cause of Death
Cheek
Epithelium
Follow-Up Studies
Humans
Lymph Nodes
Male
Neck
Neck Dissection
Neoplasm Metastasis
Parotid Gland
Prevalence
Prognosis
Rare Diseases
Recurrence
Salivary Ducts
Full Text Links
  • JKCPCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr